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The dynamics of single spike-evoked adenosine release
in the cerebellum
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Non-technicalsummaryAdenosinemodulates brain activity inbothhealth anddisease.Although
we know a lot about adenosine action, we know little about how it is released and its cellular
sources. We have previously shown that adenosine can be released in the cerebellum by a train of
action potentials. Here we have used a pharmacological agent to enhance adenosine release and
can thus study release in response to a single action potential. The release follows a waveform that
is well described by a minimal diffusion model from a temporally sharp release event. Adenosine
release has a complex, history-dependent dynamics: it can be either depressed or enhanced
depending on the stimulation pattern – similar properties to those of fast neurotransmitters such
as glutamate. Our results demonstrate that the dynamics of adenosine release will depend strongly
on the pattern of neural activity and thus constitutes a highly complex signalling pathway in the
nervous system.
Abstract The purine adenosine is a potent neuromodulator in the brain, with roles in a number
of diverse physiological and pathological processes. Modulators such as adenosine are difficult
to study as once released they have a diffuse action (which can affect many neurones) and,
unlike classical neurotransmitters, have no inotropic receptors. Thus rapid postsynaptic currents
(PSCs) mediated by adenosine (equivalent to mPSCs) are not available for study. As a result
the mechanisms and properties of adenosine release still remain relatively unclear. We have
studied adenosine release evoked by stimulating the parallel fibres in the cerebellum. Using
adenosine biosensors combined with deconvolution analysis and mathematical modelling, we
have characterised the release dynamics and diffusion of adenosine in unprecedented detail.
By partially blocking K+ channels, we were able to release adenosine in response to a single
stimulus rather than a train of stimuli. This allowed reliable sub-second release of reproducible
quantities of adenosine with stereotypic concentration waveforms that agreed well with pre-
dictions of a mathematical model of purine diffusion. We found no evidence for ATP release
and thus suggest that adenosine is directly released in response to parallel fibre firing and does
not arise from extracellular ATP metabolism. Adenosine release events showed novel short-term
dynamics, including facilitated release with paired stimuli at millisecond stimulation intervals
but depletion-recovery dynamics with paired stimuli delivered over minute time scales. These
results demonstrate rich dynamics for adenosine release that are placed, for the first time, on a
quantitative footing and show strong similarity with vesicular exocytosis.
(Received 2 September 2010; accepted after revision 15 November 2010; first published online 15 November 2010)
Corresponding authorM. J. Wall: Department of Biological Sciences, University of Warwick, Coventry CV4 7AL, UK.
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potential.
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Introduction
The neuromodulator adenosine is involved in diverse CNS
processes including sleep, locomotion and respiration,
and provides neuroprotection during hypoxia, epilepsy
and ischaemia (Boison, 2006; Dale & Frenguelli, 2009).
The actions of adenosine, via a number of G-protein
coupled cell-surface receptors, are well characterised
(Fredholm et al. 2000, 2001) and typically reduce activity
within neural networks. However, the mechanism of
adenosine release into the extracellular space and the
dynamics of its subsequent diffusion to reach and activate
these receptors are still unclear in many areas of the
brain. Adenosine release can follow extracellular ATP
metabolism from ATP released by exocytosis (Edwards
et al. 1992; Dale, 1998; Jo & Schlicter, 1999) or via gap
junction hemi-channels (Pearson et al. 2005). Adenosine
can also be transported out of the cell cytoplasmby specific
transporter proteins (Craig & White, 1993; Sweeney,
1996).
There is growing evidence that neural activity can
trigger adenosine release: trains of action potentials release
adenosine in the hippocampus (Mitchell et al. 1993),
calyx of Held (Kimura et al. 2003; Wong et al. 2006) and
cerebellum (Wall & Dale, 2007, 2008). This provides a
potentially important negative feedback mechanism to
modulate the level of activity within neural networks
and also provides a possible link between neural activity
and local blood flow (Li & Iadecola, 1994). The exact
mechanisms for this adenosine release have not been fully
elucidated, but the most detailed study has been carried
out in the cerebellum (Wall & Dale, 2007, 2008). Local
activation, within the molecular layer releases adenosine
by a process that is both action potential and Ca2+
dependent and does not appear to involve extracellular
ATP metabolism or transporter proteins (Wall & Dale,
2007). Additionally, the modulation of adenosine release
by specific G-protein coupled receptor agonists strongly
suggests the requirement of parallel fibre activity (Wall &
Dale, 2007, 2008).
Unlike the description of the effects of fast synaptic
neurotransmitters – the rise and fall of postsynaptic
potentials (PSPs) and short-term plasticity (depression
and facilitation), the dynamics of neuromodulator release
has not been characterised. Here, we use a novel
manipulation of the adenosine release mechanism to
trigger reliable pulses of neuromodulator release from
which the properties and dynamics of release can be
studied. We demonstrate that adenosine release shares
many characteristics of conventional transmitter release –
dependence on action potential width and homosynaptic
plasticity.
Methods
Preparation of cerebellar slices
Transverse slices of cerebellar vermis (400μm) were
prepared from male Wistar rats, at postnatal days 21–28.
As described previously (Wall & Dale, 2007) and in
accordance with the UK Animals (Scientific Procedures)
Act 1986, rats were killed by cervical dislocation and then
decapitated. The cerebellum was rapidly removed and
cerebellar slices were cut on a Microm HM 650V micro-
slicer (Carl Zeiss) in cold (2–4◦C) high Mg2+, low Ca2+
artificial cerebrospinal fluid (aCSF), composed of (mM):
127 NaCl, 1.9 KCl, 8 MgCl2, 0.5 CaCl2, 1.2 KH2PO4, 26
NaHCO3, 10 D-glucose (pH 7.4 when bubbled with 95%
O2 and 5% CO2). Slices were stored in normal ACSF
(1.3 mM MgCl2, 2.4 mM CaCl2) at room temperature for
1–6 h before recording.
Recording from slices
An individual slice was transferred to a recording
chamber, submerged in ACSF and perfused at 6 ml min−1
(30–32◦C). For stimulation (to evoke purine release and
excitatory postsynaptic potentials, EPSPs), square voltage
pulses (2–5 V, 200μs duration) were delivered by an
isolated pulse stimulator (ISO-STIM 01M, NPI Electro-
nics, Tamm, Germany) via a concentric bipolar metal
stimulating electrode (FHC Inc., Bowdoin, ME, USA)
placed on the surface of the molecular layer. Purine
biosensors were either positioned just above the surface
of the slice (bent so their longitudinal surface was parallel
to the stimulated molecular layer) or carefully inserted
into the molecular layer. For extracellular recording, an
aCSF filled microelectrode was placed on the same track
along which the parallel fibres travel. Parallel fibre EPSPs
will represent the sum of Purkinje cell, Bergmann glia
and molecular layer interneuron EPSPs. Extracellular
recordings were made using an EXT-10C extracellular
amplifier (NPI Electronics), filtered at 1 kHz and digitised
on-line (10 kHz) with a Micro 1401 interface controlled
by Spike2 software (v. 6.1) (Cambridge Electronic Design,
Cambridge, UK).
Biosensor characteristics
Biosensors (Llaudet et al. 2003, 2005) were obtained
from Sarissa Biomedical Ltd (Coventry, UK). Three
types of purine biosensor were used in this study.
Firstly, a screened null sensor, possessing the matrix
but no enzymes, was used to control for the release
of any non-specific electro-active interferents. Secondly,
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screened ADO biosensors (Llaudet et al. 2003) containing
adenosine deaminase, nucleoside phosphorylase and
xanthine oxidase (responsive to adenosine, inosine and
hypoxanthine). Finally, screened ATP biosensors, which
consisted of the entrapped enzymes glycerol kinase
and glycerol-3-phosphate oxidase (Llaudet et al. 2005).
Glycerol (2 mM)was included in the aCSF, as a co-substrate
required for ATP detection. A full description of the
properties of the biosensors has already been published
(Llaudet et al. 2003, 2005), but they show a linear response
to increasing concentration of analyte and are fast to
respond. Biosensors were calibrated before the slice was
present in the perfusion chamber and after the slice had
been removed, allowing measurement of any reduction
in sensitivity during the experiment. ADO biosensors
detect adenosine, inosine and hypoxanthine. In many
experiments, particularly when purines were released by
a train of stimuli in 4-AP, the precise composition of the
purines released was not defined. Therefore, in order to
calculate the concentration of purines detected by ADO
biosensors, the adenosine calibration was used to give
either μM′ or nM′ of purines (as outlined in Pearson
et al. 2001). This was possible as ADO biosensors have
an approximately equal sensitivity to adenosine, inosine
andhypoxanthine.Biosensor calibrationcurrentswerenot
affected by 4-AP. Biosensor signals were acquired at 1 kHz
with a Micro 1401 interface using Spike2 (v. 6.1) software
(Cambridge Electronics Design).
Measuring extracellular ATP breakdown
Tomeasure the extracellular breakdown of ATP, ADO and
ATP, biosensors were inserted into different molecular
layers within a transverse cerebellar slice. A perfusion
pipette (PDES-02DX, NPI Electronics) was used to inject
10μMATP (1 s pulse) into the slice. The perfusion pipette
was moved between the molecular layer containing the
ATP sensor and the molecular layer containing the ADO
sensor such that injections weremade at the same distance
from each biosensor (between 0.5 and 1mm). Injection of
aCSF produced no current on either biosensor.
Drugs
All drugs were made up as 10–100mM stock
solutions, stored frozen and then thawed and
diluted with aCSF on the day of use. Adenosine,
8-cyclopentyltheophylline (8CPT), 4-aminopyridine
(4-AP) and sodium polyoxotungstate (POM-1)
were purchased from Sigma-Aldrich (Poole, UK).
Erythro-9-(2-hydroxy-3-nonyl)adenine (EHNA),
2,3-dioxo-6-nitro-1,2,3,4-tetrahydrobenzo[f]quinoxaline
-7-sulfonamide (NBQX), 4-(8-chloro-2-methyl-
11H-imidazo[1,2-c][2,3]benzodiazepin-6-benzeneamine
dihydrochloride (GYKI 47261) and D-(–)-2-amino-
5-phosphonopentanoic acid (D-AP5) were
purchased from Tocris-Cookson (Bristol, UK).
Kynurenic acid, tetrodotoxin (TTX) and 6- cyano-
7-nitroquinoxaline-2,3-dione (CNQX) were purchased
from Ascent Scientific (Bristol, UK). ATP was purchased
from Roche (Welwyn Garden City, UK).
The data are presented as means± standard error
of the mean (S.E.M.). Statistical analysis was performed
using Student’s t test. The significance level was set at
P < 0.05.
Results
Adenosine release can be evoked in the molecular layer of
cerebellar slices by trainsof actionpotentials andmeasured
in real-time by an ADO biosensor placed on the slice
surface (Wall & Dale, 2007). Several lines of evidence
suggest that parallel fibre activity is required for this
release and that parallel fibres may themselves directly
release adenosine (Wall & Dale, 2007, 2008). We have
taken the novel approach of enhancing the probability
of adenosine release using the K+ channel blocking drug
4-aminopyridine (4-AP). This has allowed us to measure
release of the purine adenosine in response to a single
stimulus and thus to investigate its release properties in
unprecedented detail.
4-AP increases action potential-dependent
purine release
Microelectrode biosensors (Llaudet et al. 2003) were used
to characterise the effects of 4-AP on molecular-layer
adenosine release. Application of 4-AP (10–1000μM)
induced a concentration-dependent increase in the ADO
biosensor current following stimulation (40–100 stimuli,
20 Hz, Fig. 1A and B). This increase was due to purine
detection, as there was no current on null sensors (n= 15,
Fig. 1A). As in control (release evoked by 40–100 stimuli
at 20 Hz in the absence of 4-AP,Wall &Dale, 2007), purine
release in 4-AP was both action potential (blocked by
0.5–1μM TTX, n= 8) and Ca2+ dependent (blocked by
zero Ca2+ aCSF, n= 3). To produce detectable adenosine
release, 40–100 stimuli (20 Hz) are normally required
(in the absence of 4-AP, Wall & Dale, 2007). However,
with increasing concentrations of 4-AP the number
of stimuli required could be decreased until a single
stimulus was sufficient (this occurred at ∼60μM 4-AP,
Fig. 1C). To investigate whether the purine released in
4-AP is adenosine, the adenosine deaminase inhibitor
EHNA was used. EHNA prevents the conversion of
adenosine to inosine and prevents ADO biosensors
detecting adenosine with no effect on the detection of the
C© 2010 The Authors. Journal compilation C© 2010 The Physiological Society
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Figure 1. 4-AP enhances purine release
A, superimposed traces from adenosine (ADO) and null biosensors
placed on the surface of the molecular layer in control and in 4-AP
(30 μM and 60 μM). Purine release (in response to fifty 20 Hz stimuli)
adenosine metabolites inosine and hypoxanthine (Wall &
Dale, 2007). Following a train of stimuli (in 60μM 4-AP),
EHNA reduced the current amplitude by 38± 3% (n= 5
slices, Fig. 1D). Thus although a proportion of the purines
released in 4-AP is adenosine, the proportion appears less
than in control conditions (∼75%, Wall & Dale, 2007).
This may reflect an inability of the EHNA to prevent the
metabolism of large quantities of released adenosine or
there may be direct release of the adenosine metabolites
inosine and hypoxanthine. In contrast, EHNA (20μM)
markedly reduced the ADO biosensor current produced
by a single stimulus (in 60μM 4-AP) by 73± 10% (n= 4
slices, Fig. 1E) and thus most of the purine released under
this condition is adenosine.
4-AP widens the presynaptic action potential
To understand how 4-AP increases purine release, we
have investigated the actions of 4-AP on synaptic trans-
mission at parallel fibre synapses, since parallel fibre
(PF) activity is required for adenosine release in control
(50–100 stimuli at 20 Hz in the absence of 4-AP, Wall &
Dale, 2007). Application of 4-AP produced an increase in
the amplitude of PF EPSPs (Fig. 2A). For example, at a
concentration of 30μM, 4-AP increased EPSP amplitude
from0.25± 0.05mVto1.2± 0.06mV,n= 4.The increase
in EPSP amplitude was accompanied by a reduction
in the paired pulse ratio (50ms interval, 60μM 4-AP
decreased the ratio from 1.32± 0.07 to 1.1± 0.06, n= 4,
Fig. 2B) suggesting a presynaptic increase in glutamate
release. A widening of the presynaptic parallel fibre volley
(for example 30μM 4-AP increased the volley half-width
from 0.39± 0.1 ms to 0.47± 0.03ms, n= 4, Fig. 2C) with
no significant change in volley amplitude suggests the
increase in glutamate release stems from enhanced release
probability rather than the recruitment of extra parallel
fibres.
was enhanced by 4-AP (no response on closely positioned null sensor).
B, summary of purine release over a range of 4-AP concentrations
(n = 4–6). C, the mean number of stimuli required to produce
detectable purine release (∼20 pA current on ADO biosensor) plotted
against 4-AP concentration (n = 5). At around 60 μM 4-AP, a single
stimulus was sufficient to produce purine release. Above 100 μM
4-AP, spontaneous purine release occurred (zero stimuli required
for release). The data are fitted with a single exponential (time
constant = 19.5 μM). Inset, ADO biosensor trace showing purine
release in response to single stimuli (in 60 μM 4-AP, a single stimulus
was given every 300 s). D, superimposed traces from an adenosine
(ADO) biosensor in control (60 μM 4-AP) and in 4-AP plus EHNA
(20 μM) following electrical stimulation (60 stimuli, 20 Hz). EHNA
reduced the current amplitude by ∼40%. E, superimposed traces
from an ADO biosensor in control (60 μM 4-AP) and in the presence
of 4-AP plus EHNA (20 μM). Purine release (following a single stimulus)
was greatly reduced by EHNA. Thus virtually all the current at the peak
(arrow) was produced by adenosine.
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The properties of adenosine release resemble
glutamate release from parallel fibres
Data from PF synapses demonstrate that 4-AP increases
transmitter release by widening the presynaptic (parallel
fibre) action potential. Since adenosine release in control
(absence of 4-AP) is either from parallel fibres or parallel
fibre activity is required for release (Wall&Dale, 2007), the
amount of purines released in 4-AP should correlate with
Figure 2. 4-AP enhances parallel fibre glutamate release by
widening the action potential
A, graph plotting the amplitude of individual parallel fibre (PF) EPSPs
against time. Application of 10 and then 30 μM 4-AP increased EPSP
amplitude. B, superimposed averages of paired EPSPs (interval
50 ms) in control and in 30 μM 4-AP. The EPSPs were normalised to
the amplitude of the first EPSP in control to illustrate the reduction in
paired pulse facilitation produced by 4-AP. C, left panel, averages of
the presynaptic volley (parallel fibre action potential) in control (thin
line) and in 60 μM 4-AP (thick line). Right panel, the volleys
superimposed showing the increase in volley duration produced by
4-AP with no increase in volley amplitude. Thus the increase in
glutamate release stems from widening of the action potential
rather than recruitment of additional parallel fibres.
parallel fibre volley width. Increasing concentrations of
4-AP produced greater widening of the parallel fibre volley
(Fig. 3A) and, as predicted, there was a close correlation
(r = 0.92)between thewidthof theparallel fibre volley and
the amount of purines released (Fig. 3B, filled circles).
Enhanced adenosine release is partially mediated by
glutamate receptor activation
In control conditions (absence of 4-AP), adenosine release
is not affected by antagonists of ionotropic glutamate
receptors (release evoked by 50–100 stimuli at 20 Hz, Wall
Figure 3. Adenosine release grades with spike width
A, parallel fibre-volley half-width plotted against 4-AP concentration
(n = 4–6). B, the concentration of purines released plotted against
volley half-width in control (filled circles) and in 20–50 μM CNQX
(open circles). The linear fit in control (slope of 3.1, R value of 0.92)
and CNQX (slope of 1.85, R value of 0.96) demonstrates that 40%
of the signal is glutamate receptor dependent (all data from 40–100,
20 Hz stimuli, n = 4–6). C, superimposed traces from an adenosine
(ADO) biosensor placed on the surface of the molecular layer in
control (60 μM 4-AP) and in 4-AP plus CNQX (20 μM). Adenosine
release (in response to fifty 20 Hz stimuli) was reduced by ∼60% by
CNQX.
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&Dale, 2007).However, the greater amountof synaptically
released glutamate in 4-AP could lead to the activation
of additional cellular components which subsequently
release purines. Application of the glutamate receptor
antagonist CNQX (20μM) reduced the ADO biosensor
current (in 60μM 4-AP) from 94± 19 pA to 37± 12 pA
(∼60% block, Fig. 3C, n= 6). Purine release was also
reduced (by a similar amount) by other glutamate receptor
antagonists: kynurenate (5 mM, n= 3) and NBQX (5μM,
n= 3). When glutamate receptors were blocked (CNQX
20–50μM) there remained a strong correlation between
parallel fibre volley width and the amount of purines
released (R= 0.96, Fig. 3B, open circles) over a range of
4-AP concentrations with the slope of the relationship
shallower than control (1.8 vs. 3.1, ∼60% reduction) as
expected. The close correlation of residual purine release
with volley width in CNQX provides further evidence
that glutamate receptor-independent extracellular purines
arise from direct release from parallel fibres.
No evidence that purine release results from
extracellular ATP metabolism
Previous results suggest that released adenosine does not
arise from extracellular ATP metabolism (Wall & Dale,
2007); however, due to the small amount of adenosine
released and the low potency of nucleotidase inhibitors, it
was not possible to completely exclude rapid breakdownof
ATP before biosensor detection (Wall &Dale, 2007, 2008).
We now take advantage of the significantly increased
amounts of purines released in 4-AP to enhance the
likelihood of biosensor detection of any putative upstream
ATP. In 300μM 4-AP, stimulation (40–100 stimuli, 20 Hz)
resulted in a strong purine signal (1.8± 0.2μM′, n= 5)
with nomeasurable signal on the ATP biosensor (Fig. 4A).
Even if the experiment was repeated in the presence
of the most potent cerebellar nucleotidase inhibitor
(Wall et al. 2008), POM-1 (100μM), no ATP signal
was revealed and the amount of purine detected was
not significantly reduced (1.8± 0.2 vs. 1.6± 0.5μM′,
n= 5, Fig. 4B). To investigate the speed and extent of
extracellular ATP metabolism, 10μM ATP was injected
into the slice (1 s pulse, see Methods). Large responses
were produced on ATP biosensors (91± 23 pA equivalent
to 1.1± 0.2μM of ATP) with very little current on
ADO biosensors (14± 7 pA equivalent to 65± 21 nM
adenosine, n= 5, Fig. 4C). This provides strong evidence
that ATP metabolism is insufficiently fast to prevent
detection of putative upstream ATP during purine release
and consequently that detected purines do not arise from
extracellular ATP metabolism.
Single-stimulus-induced adenosine release
The stimulation of adenosine release with single stimuli
(in 60μM 4-AP) has the advantage that the diffusive
transport of adenosine within tissue can be examined
from a source event that is highly localised in time,
whereas in control (absence of 4-AP) the stimulation
protocol to produce similar quantities of adenosine
requires 2–5 s of continuous stimulation (Wall & Dale,
2007). The pharmacology of single-stimulus release is
similar to the release from multiple stimuli in control
(50–100 stimuli at 20 Hz, Wall & Dale, 2007): release
is action potential dependent (blocked by 1μM TTX,
n= 3 slices) and Ca2+ dependent (reversibly blocked by
zero Ca2+ aCSF, n= 3 slices), and the majority of the
purine released is adenosine (∼75%, Fig. 1E). However
unlike control (absence of 4-AP) adenosine release, a large
proportion of the adenosine released by a single stimulus
Figure 4. No ATP detected despite enhanced purine release
A, traces from an adenosine (ADO) biosensor placed on the surface of the molecular layer and an ATP biosensor
placed within the same molecular layer in the presence of 300 μM 4-AP. Following stimulation (60 stimuli, 20 Hz),
a significant purine concentration was detected by the ADO biosensor but there was no current on the ATP
biosensor. B, traces from an adenosine (ADO) biosensor placed on the surface of the molecular layer and an
ATP biosensor placed within the same molecular layer in the presence of 60 μM 4-AP. Blocking ectoATPAses with
POM-1 (100 μM) did not reveal an ATP signal and did not reduce the ADO biosensor current. C, traces from an
adenosine (ADO) biosensor and ATP biosensor placed within the molecular layer following a 1 s injection of 10 μM
ATP. The ATP was injected at an equal distance (∼1mm) from the ATP and ADO biosensors. The large ATP and small
ADO biosensor currents demonstrate that the extracellular breakdown of ATP does not appear efficient enough
to prevent biosensor detection of putative upstream ATP (top scale bar ATP, bottom scale bar ADO).
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Figure 5. Dynamics of single and paired stimulus-induced
adenosine release
Aa, ADO biosensor waveform in response to a single stimulus (black)
compared to model (green). Ab, the deconvolved data (black) and
model (green) from raw data in Aa. Inset shows exponential fit to
data (time constant 60 s). Ba, ADO biosensor and Bb deconvolution
waveforms (time constant 35 s) from a different experiment during
paired-pulse stimulation protocols showing depression on minute
time scales (interval 120 s, 60 s, 30 s) but strong facilitation at very
short time scales (50 ms). C, ADO biosensor traces for a single
stimulus and a pair of stimuli (interval 50 ms) highlighting the
increased amplitude; the expected signal for twice the
single-stimulus response is shown for comparison (red). D, effects of
manipulation of extracellular Ca2+ and glutamate receptor block
(with CNQX in 2.4 mM Ca2+) on the paired-pulse ratio for ADO
biosensor amplitude and parallel fibre EPSP amplitude (for 50 ms
intervals). Inset, ADO biosensor traces for a single stimulus and a
50 ms interval pair of stimuli recorded in 20 μM CNQX (2.4 mM
Ca2+). E, superimposed ADO biosensor traces (deconvolved and
then reconvolved with baseline removed) for pairs of stimuli,
is glutamate receptor dependent (20μM CNQX reduced
the current amplitude by 80± 2%, n= 5). The selective
AMPA receptor antagonist GYKI 47261 (10μM) blocked
41± 4% (n= 4) of the biosensor current and thus amajor
proportion of the adenosine release stems from AMPA
receptor activation.
Diffusion model and deconvolution analysis
Single stimuli (300 s interval, 60μM 4-AP) produced
biosensor currents with a fast rise and slower exponential
decay (Fig. 5Aa). The purine biosensor measures the
combined concentration P= A+ I +H of adenosine (A),
inosine (I) and hypoxanthine (H) in the neural tissue. The
assumptions in thisminimal diffusion model are: that the
bulk (tissue-level) diffusion constant D for each purine is
similar; that the breakdown of hypoxanthine in tissue is
slow compared to purine loss from the slice surface; and
that the purines are released from the middle of the slice
(z = 0) at a rate F(t) uniformly per unit area of slice. If the
variable zmeasures thedistancenormal to the slice surface,
then the combined purine concentration P(t) obeys the
following diffusion equation:
∂P
∂t
= D ∂
2P
∂z2
+ F (t)δ(z).
The concentration at the two principal surfaces of the
slice (z = ±h/2) is assumed to be zero as it is open to the
large volumeof thebathingmediumwhich is continuously
washed out. Considering the example first of an impulse
delivering a unit amount of purine per unit area at t = 0
so that F(t)= δ(t), the solution for the concentration p(t)
at a later time is:
p (t) = 2
h
∞∑
m=0
exp (−t/τm) cos
( z
h
(2m + 1)π
)
where the time constants are a function of the slice
thickness h:
τm = h
2
D(2m + 1)2π2 .
Hence, the longest decay (zero modem= 0) measured by
the biosensor at the tail of thewaveform is a function of the
slice thickness and not purely a function of intrinsic tissue
inter-pulse intervals of 30 s, 60 s and 120 s, with an interval of
300 s between pairs. Increasing the inter-stimulus interval reduced
the amount of depression. Inset, raw data used in E. F, graph plotting
ADO biosensor paired-pulse amplitude ratio versus stimulation inter-
val (log scale, n = 4–6). The decay in facilitation is fitted with a single
exponential (time constant 0.9 s, R value 0.99) and the recovery from
depression is fitted with a single exponential (time constant 280 s, R
value 0.95). All traces in this figure were in 60 μM 4-AP.
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parameters, like the diffusion constant or dependent on
the properties of the biosensor (which have been omitted
from this analysis). The biosensor is placed on a surface of
the slice z= h/2 and measures the flux of purines leaving
the slice J(t). This flux is minus the gradient of the density
multiplied by the diffusion constant D. Using the lower
case j(t) for the case of a unit impulse of purine per unit
area injected at a time t= 0, we have:
j (t) = 2Dπ
h2
∞∑
m=0
exp(−t/τm)(2m + 1)(−1)m.
This minimal theoretical waveform is compared to an
experimental measurement in Fig. 5Aa and agrees well
with initial rise and exponential fall. This implies that
the response time of the biosensor is sufficiently fast to
faithfully record the purine signal. If there are a series of
purine pulses of concentration per unit area ck released at
times tk then from the linearity of the diffusion equation
the purine flux on the biosensor will be the sum:
J (t) =
∑
k
ckj (t − tk).
A signature of the linearity will be that the decay of
the waveform is (more-or-less) constant regardless of the
amplitude (for example see Figs 5B and 6C).
A minimal diffusion model of adenosine transport in
tissue predicts a biosensor current waveform j(t) of the
form:
j = 2Dπ
h2
∞∑
m=0
e−
t
τm (2m + 1)(−1)m (1)
where D is the diffusion constant of purines within tissue
and h is the slice thickness. This formula resolves the
biosensor current into a sum of modes of increasingly
short time constants τm = h2D(2m+1)2π2 . For times greater
than h2/D the only significant mode remaining is the zero
order time constant τ0 = h2Dπ2 – the slow decay seen on
the biosensor. It can be noted that the model suggests
this reflects loss of purines from the slice surface into the
bathing medium. In Fig. 5Aa the time constant measured
from an exponential fit (to the early component of the
decay to avoid contamination from drift – see below)
was 60 s. For a slice thickness of 400μm this gives a
Figure 6. Depression of adenosine release during repetitive single-pulse stimulation
A, ADO biosensor trace (∼2 h experiment) demonstrating stimulus interval-dependent levels of purine release with
the deconvolutions (time constant 60 s) shown below. B, details for stimulus intervals of 300 s, 120 s, 60 s, 30 s
(as marked) with deconvolutions shown below. An exponential fit (time constant 60 s) is shown in the in 120 s
detail panel. The deconvolutions allowed for the amplitudes of overlapping adenosine waveforms to be accurately
measured. C, detail of the deconvolved ADO traces for the intervals 300, 120, 60, 30 (same colour key) scaled to
same amplitude showing waveform invariance. D, pooled data from multiple experiments including a return to
300 s stimulation to test recovery. There was an increase in amplitude during the 300 s period but it was small.
E, recovery was greater for shorter duration experiments (stimulation period: three 300 s, four 120 s and three
300 s) in which a recovery of 80% was seen (panel shows amplitude mean and standard deviation).
C© 2010 The Authors. Journal compilation C© 2010 The Physiological Society
) at University of Warwick on March 23, 2011jp.physoc.orgDownloaded from J Physiol (
J Physiol 589.2 Cerebellar adenosine release 291
model-dependent estimate of the diffusion constant of
D ≈ 270μm2 s−1. Using these parameters extracted from
the decay, the full waveform prediction can be compared
to experiment and in Fig. 5Aa can be seen to be in good
agreement capturing the initial rise and peak well.
This comparison with the initial component can be
further examined by adapting a standard deconvolution
method used in the analysis of intracellular recordings
(Neher & Sakaba, 2001; Richardson & Silberberg, 2008).
This procedure removes the slow exponential decay to
reveal the fine details of the waveform. The linearity of
the summed purine concentration allows for a simple
deconvolution procedure to be applied to the signal. This
procedure removes the long decay and leads to a trace
of well separated deconvolved pulses. For cases where
the original waveform tail is exponential, such as in the
sum of post-synaptic potentials in intracellular voltage
traces (Neher & Sakaba, 2001; Richardson & Silberberg,
2008) and the case of purine waveforms considered here,
the deconvolution procedure is particularly simple and
is achieved by differentiating the signal, multiplying it
by the long time constant τ0 (which can be measured
experimentally by fitting the purine waveform in a
semi-log plot, see inset to Fig. 5Aa) and then adding it
back to itself:
d(t) = τ0 dj
dt
+ j ,
see Fig. 5Ab. In terms of the model the deconvolved trace
d(t) is:
d(t) = τ0 dj
dt
+ j
= 2Dπ
h2
∞∑
m=1
exp(−t/τm)(2m + 1)(−1)m
(
1 − τ0
τm
)
in which it can be seen that the m= 0 mode is absent.
Comparison of this with the data provides a finer test of
the model (also plotted in Fig. 5Ab) and its assumptions.
The deconvolution procedure is particularly useful
for measuring the amplitude of overlapping wave-
forms, for example see Figs 5B and 6A and B. The
method is to deconvolve the waveform and then crop
out the deconvolved pulses and reconvolve (reverse the
deconvolution process) using the formula:
A(t) =
∫ t
−∞
dt′
τ0
d(t′) exp(−(t − t′)/τ0).
This yields separated ADO waveforms from which the
amplitudes can be directly measured, Figs 5B and E and
6B. Further details of the methodology (applied to intra-
cellular voltage traces) can be found in Richardson &
Silberberg (2008). Even at this higher level of detail the
agreement between model and experiment is close. Given
that the model is predicated on an instantaneous impulse
of adenosine into the tissue, this close match between
theory and experiment suggests the single-stimulus release
event is highly localised in time with a subsecond
duration.
Plasticity of the waveform amplitude
To investigate the dynamics of the quantity of adenosine
released under multiple single-stimulus events we first
used apaired-pulse protocol. Inter-pulse intervals between
50ms and 120 s were used with a 300 s interval between
pairs. However, because the adenosine waveform has a
slow decay (in the range of 50–150 s, but constant for
a particular slice) the second waveform is often super-
imposed on the tail of the preceding one, complicating
accurate amplitude measurement. In analogy with the
treatment of intracellular recordings (Neher & Sakaba,
2001; Richardson & Silberberg, 2008) we applied the
deconvolution method (outlined above) to resolve the
pulses and allow for accurate amplitude measurement
of overlapping waveforms (see Figs 5B and 6B). The
plasticity of adenosine releasewas complex exhibitingboth
facilitation and depression, depending on the stimulus
interval.
Facilitation over millisecond time scales. At short inter-
vals marked facilitation occurred, with significantly more
adenosine released from the second stimulus compared to
thefirst (50ms interval, paired-pulse ratio1.9± 0.1,n= 8,
Fig. 5C and D). To investigate the facilitation mechanism,
extracellular Ca2+ concentrations were varied. Facilitation
at 50ms intervals was significantly (P < 0.05) increased
in low Ca2+ (1.5 mM, paired pulse ratio 3± 0.2, n= 4,
Fig. 5D) and significantly (P < 0.05) decreased in high
Ca2+ (5 mM, paired-pulse 0.6± 0.1, n= 4, Fig. 5D). The
pairedpulseplasticityofparallel fibreEPSPs (and therefore
glutamate release) was also Ca2+ dependent (Fig. 5D).
To investigate whether glutamate receptor activation is
required for the facilitation of adenosine release at short
intervals, glutamate receptors were blocked (with 20μM
CNQX). CNQX abolished the facilitation of adenosine
release (paired pulse ratio 0.75± 0.1, n= 6, Fig. 5D, inset)
suggesting that the facilitation does require glutamate
receptor activation.
Depression over minute time scales. As the inter-pulse
interval was increased, the degree of facilitation decreased
to be replaced by depression. At 30 s intervals the
second pulse was almost absent and was seen to recover
gradually for stimulations at 60 s and 120 s intervals
(Fig. 5E). These dynamics can be captured by adapting
a resource-depletion model used to model synaptic
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depression in the context of fast neurotransmitter vesicle
release (Tsodyks & Markram, 1997) of the form:
dS
dt
= S0 − S
τs
+ f S
∑
δ(t − tk) (2)
where S(t) is the current level of releasable purine stores,
S0 is the maximum level of the store, τS is the restock
time constant and f is the fraction of the store (evaluated
just before the release event) released on each stimulation
times tk . Hence on the arrival of a stimulus the quantity
of purine released is fS(t). From Fig. 5E it is inferred that
the fraction f of stores released is very close to 1 (under
single stimulation in 60μM 4-AP, see Discussion) so that
on stimulation the entire current store S(t) is released,
depleting the store to zero. This predicts an exponential
recovery from full depletion so that the releasable stores
follow the equation:
S(t) = S0
(
1 − e− tτS
)
.
Summary of paired-pulse plasticity. The interval-
dependent plasticity is summarised in Fig. 5F . Facilitation
decreased exponentially with increasing intervals of
stimulation with a time constant of 1.0 s. Depression
recovered exponentially with increasing intervals of
stimulation with a time constant of 280 s, which can be
identified with the parameter τS of the depletion–restock
model. The presence of facilitation and depression within
the same stimulated pathway suggests that facilitation
involves the recruitment of an additional adenosine
source, presumably via increased glutamate receptor
activation.
Depression and recovery during continued
stimulation
Cerebellar networks receive on-going activation in vivo
and so to further investigate depression and recovery over
minute time scales we examined the amplitude dynamics
under continuous stimulation with periods in the range
of 30–300 s (Fig. 6A, n= 5 slices). Period-dependent
amplitudes were seen with shorter periods leading to
ADO waveforms of lower amplitude, as expected from
the paired-pulse protocol and store depletion–restock
model. Note that the mean offset from baseline for 60 s
and 30 s stimulation are similar due to the amplitudes
halving as the period doubles. This is predicted from the
resource-depletionmodel for stimulations periods shorter
that the restock time constant for which the released stores
are expected to follow the formula S(T)≈ S0T/τS where T
is the stimulation period. The implication is that at high
stimulation rate the net amount of adenosine released
per unit time S(T)/T = S0/τS becomes independent of
stimulation frequency 1/T and is limited by themaximum
store level and the restock rate 1/τS; this is a feature also
seen in vesicle-release dynamics of fast neurotransmitters
(Tsodyks & Markram, 1997).
The fine details of the waveforms are also shown
in Fig. 6A and B through deconvolution of the ADO
biosensor traces. The deconvolvedwaveforms for different
stimulationperiods are shown tobe invariant to the period
of stimulation in Fig. 6C showing constancy of the under-
lying release process with a change only in its degree. In
Fig. 6D mean ADO biosensor waveform amplitudes are
plotted as a function of stimulation interval, with a period
of 300 s intervals performed at the end of the experiment
tomeasure the degree of recovery. The amplitude doubled
from the 30 s period epoch to the 300 s period epoch but
regained only 25% of its initial amplitude when compared
to the earlier 300 s period epoch. This partial recovery
is not consistent with the paired pulse data, in which
full recovery was consistently seen after ∼300 s. Reasons
for the discrepancy could be an additional depression or
depletion mechanism acting over a longer time scale than
τS or, given the duration of the experiments (2 h) and
number of intervening purine-releasing stimuli (>50), a
degradation of the purine production in the slice. The
latter reason is consistent with additional experiments of
shorter duration and stimulation number (three 300 s,
five 120 s, three 300 s concurrent periods) in which the
recovery was 81± 3% (n= 4, Fig. 6E).
Discussion
In agreement with many studies (Nedergaard, 1999;
Daniel & Crepel, 2001; Mitterdorfer & Bean, 2002),
the partial block of presynaptic K+ channels prolongs
action potential duration leading to an increase in Ca2+
influx and neuronal transmitter release. At parallel fibre
synapses, EPSCs are very sensitive to spike broadening;
a 23% increase in spike width leads to a 25% increase
in total calcium influx, which doubles synaptic strength
(Sabatini &Regher, 1997). The strong correlation between
parallel fibre action potential duration and the amount
of purines released further supports the involvement of
parallel fibres in purine release. We believe that this
is the first demonstration that purine release, like that
of conventional neurotransmitters, depends upon action
potential width.
Our use of 4-AP as a tool to enhance adenosine release
has enabled us to study the release in much greater detail
in response to a single spike (more reproducible and better
defined temporally) as opposed to trains of spikes, which
will exhibit more variability and are less amenable to
analysis and experimental manipulation. Nevertheless we
expect that the mechanisms we have uncovered by using
4-AP to enhance release also pertain to adenosine release
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under more physiological conditions in the absence of
4-AP.
A significant component of the adenosine release
is glutamate receptor dependent
The glutamate receptor-mediated component of purine
release, revealed in 4-AP, may arise because the
increased release of glutamate activates additional cellular
components. The glutamate could feed back to enhance
release via presynaptic glutamate receptors, for example
via facilitatory kainate autoreceptors that are present
on parallel fibre terminals (Delaney & Jahr, 2002). Or
the glutamate could activate a peri/postsynaptic cellular
component leading to purine release. AMPA/kainate
receptors are present on Bergmann glial cells (Clark &
Barbour, 1997; Bordey & Sontheimer, 2003; Bellamy &
Ogden, 2006) and there is evidence that glial cells can
release adenosine, although this is in response to hypo-
xia/ischaemia (Martin et al. 2007). AMPA receptors are
also present on the axons ofmolecular layer interneurones,
which have been suggested to release ATP (Piet & Jahr,
2007; Rossi et al. 2008). This seems an unlikely source of
the detected purines as we have been unable to detect any
ATP (see below).
Evidence is against adenosine arising
from extracellular ATP metabolism
Even with increased purine release, it was not possible to
measure any extracellular ATP release. The limit of ATP
detection is ∼60 nM producing 10 pA of current on the
ATP biosensor (Wall & Dale, 2007). In the presence of
300μM4-AP,∼1.8μMof purines was detected and thus to
be below the limits of detectionmore than 96%of the ATP
has to be broken down before reaching the ATP biosensor.
The injection of pulses of ATP into cerebellar slices and
its subsequent measurement on ATP biosensors suggests
that ATP metabolism is not efficient enough to remove
ATP before detection. Application of POM-1, a potent
ecto-ATPase inhibitor (blocking ∼60% of ATP break-
down, Wall et al. 2008) did not reveal ATP release and did
not reduce thepurine signal. Thuswe areunable toprovide
any evidence that the action potential-dependent release
of purines arises from extracellular ATP metabolism.
Increases in Bergmann glia intracellular Ca2+
concentration following parallel fibre stimulation can
be blocked by pyridoxal phosphate 6-azophenyl-
2′,4′-disulfonic acid (PPADS) suggesting the release ofATP
(Beierlein & Regehr, 2006; Piet & Jahr, 2007). The source
of this ATP could bemolecular layer interneurones (Piet &
Jahr, 2007). Although our stimulus will activate molecular
layer interneurones (directly or via AMPA receptors), we
were unable to detect any ATP. Thus the amount of ATP
released must be either very small or highly localised and
is therefore unlikely to account for the large adenosine
signals we observe.
Plasticity of adenosine release in response
to single stimuli
In the presence of 4-AP it was possible to release
adenosine in response to a single stimulus (equivalent
to a single action potential, but see Isope et al. 2004),
which has allowed us to investigate adenosine release
with unprecedented detail. The resulting waveforms of
adenosine release were highly reproducible and featured a
fast rise followed by an exponential decay. The waveform
was accurately described by a minimal diffusion model
that accounted for loss of purines via the slice surface. The
close agreement with the rise of the waveform suggests
that the adenosine release is a sharp event, taking place
over a subsecond time scale.
Paired stimuli illustrated a rich history-dependent
dynamics for the amplitude of released adenosine. Both
facilitation and depression were seen depending on the
inter-pulse interval. Facilitation of adenosine release
occurred at short inter-pulse intervals (less than 500ms)
and was dependent on extracellular Ca2+ concentration as
might be expected for conventional exocytosis of neuro-
transmitter. However, this facilitation was abolished by
blocking glutamate receptors. One hypothesis that could
possibly explain the data is that incomplete clearance of
the glutamate released by the first stimulus coupled with
additional glutamate release from the second stimulus
leads to greater glutamate overspill and activation of
previously naive cellular components. There is evidence
for the overspill of parallel fibre glutamate, provided by
experiments investigating the activation of Purkinje cell
metabotropic glutamate receptors (mGluRs). The firing
of one or two action potentials does not activate peri-
synaptic mGluRs, but firing five action potentials (at
100 Hz) releases enough glutamate to activate mGluRs
(Brasnjo & Otis, 2001). Thus if enough glutamate is
released it cannot be cleared before entry into the peri-
synaptic space. Components that could be activated by
glutamate include presynaptic parallel fibres (Delaney &
Jahr, 2002), perisynaptic Bergmann glia (Clark&Barbour,
1997; Bordey & Sontheimer, 2003; Bellamy & Ogden,
2006) or postsynaptic interneurones (Rossi et al. 2008).
From the current data it is not possible to distinguish
between these potential additional sources of adenosine.
With longer inter-pulse intervals (30–120 s), depression
of adenosine release dominated. Using trains of stimuli,
we found that the amount of adenosine released per
unit time remained constant, which is characteristic of
a simple depletion and refill model. The constancy of
the underlying waveform, studied in fine detail using
deconvolution analysis, suggests that depression results
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simply from a reduction in the amount of adenosine
released rather than changes in the actual release process.
There could be true depletion of adenosine stores, as
demonstrated following hypoxia (Pearson et al. 2001) and
in the hypothalamic defence reflex (Dale et al. 2002), or
a functional depletion as a result of reduced glutamate
receptor activation. We have little evidence for the latter
but the probable saturation of glutamate receptors in
the synaptic cleft means it is not possible to completely
exclude it.
Adenosine dynamics in control conditions
In this study the amplification of the adenosine release
process using 4-AP was used to produce waveforms
from which the adenosine transport in tissue and history
dependence of the quantity released could be reliably
measured.Because thediffusionand transport is additively
linear, even at high concentrations (this is seen in the long
decay being constant regardless of waveform amplitude),
it can be expected that the stock depletion–restock
model in eqn (2) holds for adenosine release due to
stimulation in concentrations of 4-AP that are less than
60μM. The history dependence, however, will be different.
Consideration of eqn (2) and the number of stimuli
required to produce a constant, measureable signal in
various concentrations of 4-AP (Fig. 1C) suggests that in
control eqn (2) would still hold, but with the fraction f
of adenosine released from stores of the order of 0.5–2%
per stimulus, rather than the 100% in 60μM 4-AP. Given
that the restock time constant is of the order of hundreds
of seconds and that in vivo parallel fibre activation will
be of relatively high rate, the model predicts that the
adenosine release will nevertheless be in the depleted
restock-rate-limited regime, despite the smaller fraction
of release.
This is thefirst time that adenosine release and transport
have been examined in such fine quantitative detail. We
have demonstrated that adenosine release can have a rich
and complex dynamics, sharing many properties of the
better studied neurotransmitters including rapid release,
dependence on spike width, reproducible waveforms, and
history-dependent amplitudes showing both facilitation
and depression.
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